David Rodman sells shares; Mineralys Therapeutics (NASDAQ: MLYS) Form 144 listing
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
David Rodman filed a Form 144 reporting proposed and recent sales of common stock. The notice lists a proposed sale of 6,348 shares tied to an exercise of employee stock options on 04/14/2025. The filing also records multiple completed sales between 01/09/2026 and 04/13/2026, including 14,058 shares sold on 04/13/2026 for $373,086.81.
Positive
- None.
Negative
- None.
Key Figures
Proposed shares to be sold: 6,348 shares
Largest recorded sale in excerpt: 14,058 shares
Example sale proceeds: $373,086.81
+1 more
4 metrics
Proposed shares to be sold
6,348 shares
tied to exercise of employee stock options on 04/14/2025
Largest recorded sale in excerpt
14,058 shares
sold on 04/13/2026 for $373,086.81
Example sale proceeds
$373,086.81
proceeds from 14,058 shares on 04/13/2026
Other sample sale
6,348 shares
sold on 01/12/2026 for $205,142.99
Key Terms
Form 144, exercise of employee stock options, proceeds
3 terms
Form 144 regulatory
"listed as a filing reporting proposed sale under Rule 144"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
exercise of employee stock options financial
"Exercise of employee stock options | Mineralys Therapeutics, Inc."
proceeds financial
"14,058 | 373086.81 appears as sale proceeds for a trade"
FAQ
What does David Rodman's Form 144 for MLYS report?
It reports a proposed sale of 6,348 shares tied to option exercise and multiple completed sales between 01/09/2026 and 04/13/2026. The filing lists trade dates, share counts, and sale proceeds for each transaction.
What recent sales by Rodman are recorded in the filing?
The filing records multiple sales from 01/09/2026 through 04/13/2026, including notable entries of 14,058 shares sold on 04/13/2026 for $373,086.81 and other dated share/price lines.